Peptic Ulcer Drugs Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Peptic Ulcer Drugs Market by Product Type (H2 receptor Antagonists, Proton Pump Inhibitors (PPIs), Antacids, Ulcer Protective Drugs, Potassium-Competitive Acid Blockers (P-CAB), Antibiotics, Others), By Formulation (Oral tablets, Effervescent Tablets, Effervescent Granules, Syrups, Injections), By Application (Oral tablets, Effervescent Tablets, Effervescent Granules, Syrups, Injections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Peptic ulcer drugs market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The report on global gives historical, current, and future market sizes (US$ Mn) on the basis of product type, formulation, application, distribution channel, and regions. This report studies global dynamics elaborately to identify the current market trends and drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global report includes competition analysis with vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global Peptic ulcer drugs market to better equip clients with possible investment opportunities across the regions and market unmet needs (Product Opportunities). Key stakeholders of the global report include suppliers, manufacturers, marketers, policy makers, and agronomists engaged in global activities. low profile additives market is consolidating as large players complementing each other’s businesses by means of collaborations, agreements and acquisitions. Peptic ulcers are used in the treatment of certain types of gastrointestinal disorders that include gastric ulcers, gastritis, and duodenal ulcers or gastroesophagal reflux disease (GERD). These drugs minimize the amount of acid produced by the stomach. The most common symptoms associated with peptic ulcer include abdominal pain, vomiting, belching, poor appetite, and weight loss. Peptic ulcers can be treated by using various drugs such as proton pumps inhibitors (PPIs), H2 receptor antagonists, antacids, and antibiotics among others In February 2018, Strides Shasun decided to launch the Ranitidine 150 mg over the counter drug in U.S. for the treatment of peptic ulcers

Peptic Ulcer Drugs Market

MARKET SUMMARY
-
x
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–X%
  • Largest Market– North America
  • Fastest Market- Europe

Peptic Ulcer Drugs Market Analysis

  • Peptic Ulcer Drugs Market expanding at significant CAGR during the forecast period 2022 to 2028
  • Players focusing on mergers and acquisitions strategies to retain market position.
  • For instance, In February2018, Strides Shasun decided to launch the Ranitidine 150 mg over the counter drug in U.S. for the treatment of peptic ulcers
Market Leaders
  • Pfizer, Inc. (U.S.)
  • Boehringer Ingelheim GmbH (Germany)
  • Abbott Laboratories (U.S.)
  • Takeda Pharmaceuticals Co. Ltd (Japan)
  • GlaxoSmithKline plc (UK)
Peptic Ulcer Drugs Market

Drivers and Restraints

Increase in the global geriatric population, rise in prevalence of peptic ulcers due to change in food habits, and increase in the consumption of tobacco and alcohol are key factors surge the global peptic ulcer drugs market. Moreover, rise in R&D for the development of newer drugs, rise in number of drug induced peptic ulcer cases, availability of cost-effective drugs, and rise in awareness about the peptic ulcers among the people are anticipated to surge the global peptic ulcer drugs market over the forecast years. However, adverse effects associated with the drugs, patent expiries of block buster drugs, poor pipeline products, and changes in pricing policies are hamper the growth of global peptic ulcer drugs market.


Peptic Ulcer Drugs Market Regional Analysis

North America dominates the market

North America peptic ulcer drugs market is poised to grow due to rise in R&D for the development of newer drugs, increase in the prevalence of peptic ulcers due to change in lifestyle, and rise in health awareness among the people are propel the market. A lucrative growth observed in Europe peptic ulcer drugs market attributed to rise in consumption of tobacco and alcohol, high adoption of peptic ulcer drugs over various surgeries, and long term usage of various drugs such as pain medications that induce peptic ulcers are boost the market. However, Asia Pacific peptic ulcer drugs market is driving by entry of generic drugs due to patent expiries, rise in medical tourism for various surgeries, and large patient pool due to rise in geriatric population in India, china, and Japan are bolster the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
Peptic Ulcer Drugs Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Pfizer, Inc. (U.S.)
  • Boehringer Ingelheim GmbH (Germany)
  • Abbott Laboratories (U.S.)
  • Takeda Pharmaceuticals Co. Ltd (Japan)
  • GlaxoSmithKline plc (UK)
  • Yuhan Co. Ltd. (South Korea)
  • AstraZeneca plc (UK)
  • Eisai Co. Ltd. (U.S.)
  • Helicure AB (Sweden)
  • Cadila Healthcare (India)

Description

Peptic ulcer drugs market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The report on global gives historical, current, and future market sizes (US$ Mn) on the basis of product type, formulation, application, distribution channel, and regions. This report studies global dynamics elaborately to identify the current market trends and drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global report includes competition analysis with vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global Peptic ulcer drugs market to better equip clients with possible investment opportunities across the regions and market unmet needs (Product Opportunities). Key stakeholders of the global report include suppliers, manufacturers, marketers, policy makers, and agronomists engaged in global activities. low profile additives market is consolidating as large players complementing each other’s businesses by means of collaborations, agreements and acquisitions. Peptic ulcers are used in the treatment of certain types of gastrointestinal disorders that include gastric ulcers, gastritis, and duodenal ulcers or gastroesophagal reflux disease (GERD). These drugs minimize the amount of acid produced by the stomach. The most common symptoms associated with peptic ulcer include abdominal pain, vomiting, belching, poor appetite, and weight loss. Peptic ulcers can be treated by using various drugs such as proton pumps inhibitors (PPIs), H2 receptor antagonists, antacids, and antibiotics among others In February 2018, Strides Shasun decided to launch the Ranitidine 150 mg over the counter drug in U.S. for the treatment of peptic ulcers

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX